GOLGA6L3P: A Potential Drug Target and Biomarker (G100133220)

Target Name: GOLGA6L3P

NCBI ID: G100133220

GOLGA6L3P

Other Name(s): golgin A6 family like 3, pseudogene | golgi autoantigen, golgin subfamily a, 6-like 3 | GOLGA6L3 | Golgin A6 family like 3 | Putative golgin subfamily A member 6-like protein 3

GOLGA6L3P: A Potential Drug Target and Biomarker

Golgastagellin (GOLGA) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the G-protein-coupled receptor (GPCR) family and is involved in a variety of physiological processes in the body, including cardiovascular function, neurotransmission, and inflammation. GOLGA6L3P is a specific subunit of the GOLGA protein that has been identified as a potential drug target and biomarker.

The GPCR family of proteins plays a crucial role in the regulation of cellular signaling pathways. GOLGA is a key member of this family and is involved in the regulation of various physiological processes, including neurotransmission, hormone signaling, and inflammation. GOLGA6L3P is a specific subunit of GOLGA that is expressed in the brain and is involved in the regulation of neurotransmitter signaling.

GOLGA6L3P has been shown to play a role in the regulation of neurotransmitter release from nerve axons. In addition, it has been shown to interact with dopamine (D2) receptors, which are involved in the transmission of signals in the brain. GOLGA6L3P has also been shown to play a role in the regulation of neurotransmitter uptake and release in response to changes in the levels of neurotransmitters in the brain.

GOLGA6L3P has also been shown to be involved in the regulation of inflammation. It has been shown to interact with various signaling pathways, including the TLR5 signaling pathway. This pathway is involved in the regulation of inflammation and is a potential target for the development of anti-inflammatory drugs. GOLGA6L3P has also been shown to play a role in the regulation of inflammation in the brain, which is important for the development of neurodegenerative diseases.

In addition to its potential role in the regulation of neurotransmission and inflammation, GOLGA6L3P has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to interact with various signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cellular signaling pathways and is a potential target for the development of anti-cancer drugs.

GOLGA6L3P has also been shown to play a role in the regulation of cellular signaling pathways in the regulation of cell survival. It has been shown to interact with various signaling pathways, including the p53 signaling pathway. This pathway is involved in the regulation of cell survival and is a potential target for the development of anti-cancer drugs.

GOLGA6L3P has also been shown to play a role in the regulation of cellular signaling pathways in the regulation of cell migration. It has been shown to interact with various signaling pathways, including the F-actinin signaling pathway. This pathway is involved in the regulation of cell migration and is a potential target for the development of anti-cancer drugs.

GOLGA6L3P has also been shown to play a role in the regulation of cellular signaling pathways in the regulation of cell differentiation. It has been shown to interact with various signaling pathways, including the Wnt signaling pathway. This pathway is involved in the regulation of cell differentiation and is a potential target for the development of anti-cancer drugs.

In conclusion, GOLGA6L3P is a protein that has been shown to play a role in the regulation of various physiological processes in the body, including neurotransmission, neuroprotection, inflammation, and cellular signaling pathways. GOLGA6L3P is a potential drug target and biomarker and has the potential to be developed into an anti-inflammatory or anti-cancer drug. Further research is needed to fully understand the role of GOLGA6L3P in the regulation of various physiological processes in the body.

Protein Name: Golgin A6 Family Like 3, Pseudogene

The "GOLGA6L3P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GOLGA6L3P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets